Carregant...
Complications Associated with Erythropoietin Stimulating Agents (ESAs) in Patients with Metastatic Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Study
PURPOSE: To evaluate the patterns of use and the risk of thromboembolic events (TEE) associated with Erythropoietin Stimulating Agents (ESAs) in older patients with metastatic breast cancer receiving chemotherapy. METHODS: Retrospective study using the SEER-Medicare linked database. Stage IV breast...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3448281/ https://ncbi.nlm.nih.gov/pubmed/21656514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25972 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|